$CURR News: COFEPRIS (Mexico’s equivalent of the
Post# of 98052
(Total Views: 168)
Posted On: 04/05/2022 7:36:47 AM
$CURR News: COFEPRIS (Mexico’s equivalent of the US FDA) grants authorization for the manufacture, distribution and sale in Mexico of CURE’s Sildenafil, Vitamin D3, Electrolyte, Energy, and Sleep products in CURE’s patented Oral Thin Film (OTF) dose form CUREform™
OXNARD, Calif. and LAS VEGAS, March 03, 2022 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTC: CURR) a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, and Milagro Pharmaceuticals, which seeks first mover advantage in target heath & wellness markets through key collaborations, today announced their collaboration to register and sell in Mexico a number of CURE’s OTC and medical compounds that utilize CUREform™, CURE’s patented drug delivery platform for oral thin film (OTF). Cure is in discussions with several large distributors in Mexico and Latin America.
OXNARD, Calif. and LAS VEGAS, March 03, 2022 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTC: CURR) a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, and Milagro Pharmaceuticals, which seeks first mover advantage in target heath & wellness markets through key collaborations, today announced their collaboration to register and sell in Mexico a number of CURE’s OTC and medical compounds that utilize CUREform™, CURE’s patented drug delivery platform for oral thin film (OTF). Cure is in discussions with several large distributors in Mexico and Latin America.
(0)
(0)Scroll down for more posts ▼